| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease
|
Michel, Martin C.
|
|
2016
|
164 |
C |
p. 1-81
81 p.
|
artikel
|
| 2 |
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
|
Falcon, Beverly L.
|
|
2016
|
164 |
C |
p. 204-225
22 p.
|
artikel
|
| 3 |
Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
|
Sivaprakasam, Sathish
|
|
2016
|
164 |
C |
p. 144-151
8 p.
|
artikel
|
| 4 |
Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones
|
Pera, Tonio
|
|
2016
|
164 |
C |
p. 82-96
15 p.
|
artikel
|
| 5 |
Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy
|
Zhang, Linlin
|
|
2016
|
164 |
C |
p. 120-125
6 p.
|
artikel
|
| 6 |
Expression and role of connexin-based gap junctions in pulmonary inflammatory diseases
|
Freund-Michel, Véronique
|
|
2016
|
164 |
C |
p. 105-119
15 p.
|
artikel
|
| 7 |
Importins and exportins as therapeutic targets in cancer
|
Mahipal, Amit
|
|
2016
|
164 |
C |
p. 135-143
9 p.
|
artikel
|
| 8 |
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
|
Taylor, Charles P.
|
|
2016
|
164 |
C |
p. 170-182
13 p.
|
artikel
|
| 9 |
State-of-the-art of regulatory dendritic cells in cancer
|
Conejo-Garcia, Jose R.
|
|
2016
|
164 |
C |
p. 97-104
8 p.
|
artikel
|
| 10 |
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
|
Della Badia, Laura A.
|
|
2016
|
164 |
C |
p. 183-194
12 p.
|
artikel
|
| 11 |
The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure
|
Xu, Quanbin
|
|
2016
|
164 |
C |
p. 126-134
9 p.
|
artikel
|
| 12 |
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
|
Wigerup, Caroline
|
|
2016
|
164 |
C |
p. 152-169
18 p.
|
artikel
|
| 13 |
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future
|
Lythgoe, Mark P.
|
|
2016
|
164 |
C |
p. 195-203
9 p.
|
artikel
|
Tijdschrift beschrijving